![Toshimi Miyoshi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Toshimi Miyoshi
Direttore/Membro del Consiglio presso FUNPEP COMPANY LIMITED
Patrimonio netto: 1 M $ in data 30/06/2024
Provenienza dei contatti di primo grado di Toshimi Miyoshi
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Biotechnology | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Toshimi Miyoshi tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
RAQUALIA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree | |
Keio University | College/University | Graduate Degree | |
Lexwell Partners | Founder | ||
REGiMMUNE Corp.
![]() REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
Okinawa Protein Tomography Ltd.
![]() Okinawa Protein Tomography Ltd. Miscellaneous Commercial ServicesCommercial Services Okinawa Protein Tomography Ltd. provides polymeric molecular structure analysis services. Its technology allows imaging of macromolecules including proteins in multiple states at the single molecule-level by combining conventional electron tomography and a specifically designed 3D reconstruction program known as COMET. The firm analyzes data of molecular structures of protein samples. The company was founded by Akira Kamei on June 25, 2014 and is headquartered in Uruma, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
ANGES, INC. | Pharmaceuticals: Generic | Director/Board Member | |
TOWA PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
SOLASIA PHARMA K.K. | Pharmaceuticals: Major | Director/Board Member | |
KIDSWELL BIO CORPORATION | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Giappone | 10 |
Stati Uniti | 2 |
Settori
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni
Director/Board Member | 11 |
Independent Dir/Board Member | 5 |
Graduate Degree | 2 |
Founder | 2 |
Corporate Officer/Principal | 1 |
Contatti più connessi
Insiders | |
---|---|
Akimitsu Hirai | 7 |
Norikazu Eiki | 5 |
Hideki Tomioka | 1 |
Taketoshi Hayashi | 1 |
- Borsa valori
- Insiders
- Toshimi Miyoshi
- Connessioni Società